ANCER Trademark

Trademark Overview


On Monday, January 9, 2017, a trademark application was filed for ANCER with the United States Patent and Trademark Office. The USPTO has given the ANCER trademark a serial number of 87982539. The federal status of this trademark filing is REGISTERED as of Tuesday, February 25, 2020. This trademark is owned by EpiVax, Inc.. The ANCER trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Computer software for processing cancer/normal protein sets, identifying high-quality specific neo-antigens, and designing personalized cancer vaccines

Medical testing and analysis of cancerous and normal protein sets for identifying high-quality patient specific neo-antigens for the purpose of diagnosis and treatment

Research, development, engineering and testing services in the field of personalized cancer vaccines; providing temporary use of non-downloadable software to predict the immunogenicity of protein therapeutics, to deimmunize proteins and to design T cell vaccines
ancer

General Information


Serial Number87982539
Word MarkANCER
Filing DateMonday, January 9, 2017
Status700 - REGISTERED
Status DateTuesday, February 25, 2020
Registration Number5997775
Registration DateTuesday, February 25, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2017

Trademark Statements


Goods and ServicesComputer software for processing cancer/normal protein sets, identifying high-quality specific neo-antigens, and designing personalized cancer vaccines
Pseudo MarkANSWER
Goods and ServicesMedical testing and analysis of cancerous and normal protein sets for identifying high-quality patient specific neo-antigens for the purpose of diagnosis and treatment
Goods and ServicesResearch, development, engineering and testing services in the field of personalized cancer vaccines; providing temporary use of non-downloadable software to predict the immunogenicity of protein therapeutics, to deimmunize proteins and to design T cell vaccines

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2017
Primary Code009
First Use Anywhere DateSunday, December 11, 2016
First Use In Commerce DateSunday, December 11, 2016

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2017
Primary Code042
First Use Anywhere DateWednesday, September 11, 2019
First Use In Commerce DateWednesday, September 11, 2019

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2017
Primary Code044
First Use Anywhere DateSunday, December 11, 2016
First Use In Commerce DateSunday, December 11, 2016

Trademark Owner History


Party NameEPIVAX THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPROVIDENCE, RI 02909

Party NameEPIVAX ONCOLOGY, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressProvidence, RI 02909

Party NameEPIVAX ONCOLOGY, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressProvidence, RI 02909

Party NameEpiVax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressProvidence, RI 02903

Party NameEpiVax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressProvidence, RI 02903

Trademark Events


Event DateEvent Description
Thursday, January 12, 2017NEW APPLICATION ENTERED
Tuesday, January 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 31, 2017ASSIGNED TO EXAMINER
Friday, March 31, 2017NON-FINAL ACTION WRITTEN
Friday, March 31, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 31, 2017NON-FINAL ACTION E-MAILED
Saturday, September 30, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 30, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 22, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 22, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 8, 2018SOU TEAS EXTENSION RECEIVED
Friday, June 8, 2018SOU EXTENSION 1 FILED
Friday, June 8, 2018SOU EXTENSION 1 GRANTED
Friday, June 8, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 29, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, December 19, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, December 19, 2018SOU EXTENSION 2 FILED
Wednesday, December 19, 2018SOU EXTENSION 2 GRANTED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 29, 2019SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2019SOU EXTENSION 3 FILED
Monday, April 29, 2019SOU EXTENSION 3 GRANTED
Wednesday, May 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 12, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 31, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 31, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 10, 2019TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 10, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, December 10, 2019DIVISIONAL REQUEST RECEIVED
Thursday, January 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 9, 2020DIVISIONAL PROCESSING COMPLETE
Thursday, January 9, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 10, 2019USE AMENDMENT FILED
Saturday, January 18, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 25, 2020REGISTERED-PRINCIPAL REGISTER
Friday, January 17, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 9, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, September 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 25, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED